Edge Therapeutics (EDGE) Reports Q3 Loss of $7.08

Edge Therapeutics (NASDAQ: EDGE) reported Q3 EPS of ($7.08), versus ($2.30) reported last year.

For earnings history and earnings-related data on Edge Therapeutics (EDGE) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• Carvana (CVNA) PT Lowered to $85 at RBC Capital